Pulmonary arterial hypertension trials in Argentina

In Argentina 9 Also abroad 305

9 trials · From ClinicalTrials.gov, checked 10 November 2026. Ask the study team whether a trial fits you.

Phase 4Taking people
Initial Triple Therapy Including Parenteral Treprostinil vs Initial Double Oral Therapy in PAH Group I Patients
Where
Bahía Blanca, Buenos Aires, La Plata
Age
18 years to 75 years
People
110 worldwide
Run by
AOP Orphan Pharmaceuticals AG
See details and how to joinNCT06317805 · EU 2023-504351-26-01
Phase 3Taking people
Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
Where
CiudadAutonoma de Buenos Aires, Ciudad Autónoma de Buenos Aires, Córdoba, Río Cuarto, Rosario, San Miguel de Tucumán
Age
18 years and over
People
344 worldwide
Run by
Insmed Incorporated
See details and how to joinNCT07179380 · EU 2025-521558-40-00
Phase 3Taking people
Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT)
Where
Buenos Aires, Corrientes, Quilmes, Río Cuarto, Santa Fe
Age
18 years to 75 years
People
330 worldwide
Run by
Gossamer Bio USA, Inc.
See details and how to joinNCT06274801 · EU 2023-506334-75-00
Phase 3Taking people
A Study to Evaluate the Efficacy and Safety of Once Daily Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Arterial Hypertension (PAH)
Where
Buenos Aires, Río Cuarto, San Miguel de Tucumán
Age
18 years to 75 years
People
344 worldwide
Run by
Insmed Incorporated
See details and how to joinNCT07481981 · EU 2026-525265-48-00
Phase 3Enrolling by invitation
A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension
Where
Buenos Aires, Caba, Ciudad Autonoma Buenos Aires, Ciudad Autonoma de Buenos Aires, Córdoba, Corrientes, Mar del Plata, Rosario, Santa Fe
Age
18 years and over
People
1,000 worldwide
Run by
United Therapeutics
See details and how to joinNCT03683186 · EU 2023-509305-68-00
Phase 3Taking people
An Adaptive Program of IKT-001 in Pulmonary Arterial Hypertension (PAH)
Where
Buenos Aires
Age
18 years to 75 years
People
486 worldwide
Run by
Inhibikase Therapeutics
See details and how to joinNCT07365332 · EU 2024-520218-23-00
Phase 1/2Taking people
A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B)
Where
Buenos Aires, CABA, Río Cuarto, San Miguel de Tucumán, Santa Fe
Age
18 years to 100 years
People
232 worldwide
Run by
Novartis Pharmaceuticals
See details and how to joinNCT06649110
No phaseTaking people
Institutional Registry of Rare Diseases
Where
Buenos Aires
People
380
Run by
Hospital Italiano de Buenos Aires
See details and how to joinNCT06573723
No phaseTaking people
Pulmonary Hypertension Institutional Registry at Hospital Italiano de Buenos Aires
Where
Buenos Aires
Age
17 years and over
People
200
Run by
Hospital Italiano de Buenos Aires
See details and how to joinNCT01501838